Stroke definition

Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 24 35 1. 

Transient ischemic attack Definite Possible Minor stroke Definite Possible Note ... 

A complete history and physical examination should assess (1) presence or absence of cardiovascular risk factors or definite cardiovascular disease in the individual (2) family history of premature cardiovascular disease or lipid disorders (3) presence or absence of secondary causes of hyperlipidemia, including concurrent medications and (4) presence or absence of xanthomas, abdominal pain, or history of pancreatitis, renal or liver disease, peripheral vascular disease, abdominal aortic aneurysm, or cerebral vascular disease (carotid bruits, stroke, or transient ischemic attack). 

Additionally, chronic drug use has been linked to neuropsychological problems that in turn make it harder to stop the cycle of abuse. Psychoactive drugs by definition affect the brain, and long-term or acute exposure to psychoactive substances can be toxic. Furthermore, we know that drug abuse can increase the risks of stroke, brain injury related to accidents, malnutrition, or liver damage, all of which can adversely affect brain function as well. 

The result of the Phase II trial is information needed to determine the effective dose and the dosing regimen of frequency and duration. Specihc chnical endpoints or markers are used to assess interaction of drug and disease. There are two types of markers definitive and surrogate. For example, in the case of cancer or hypertension, the definitive markers are mortality and stroke, respectively, and the surrogate markers may be tumor size, or cancer-associated proteins p53, TGF-a in the case of cancer, and blood pressure or cholesterol level in hypertension. Statistical analysis is carried out to evaluate the... 

With this bold stroke, Boltzmann escaped the futile attempt to describe microscopic molecular phenomena in terms of then-known Newtonian mechanical laws. Instead, he injected an essential probabilistic element that reduces the description of the microscopic domain to a statistical distribution of microstates, i.e., alternative microscopic ways of partitioning the total macroscopic energy U and volume V among the unknown degrees of freedom of the molecular domain, all such partitionings having equal a priori probability in the absence of definite information to the contrary. 

Except for continuous weighing, control of the flow of solids is less precise than that of fluids. Several devices used for control of feed rates are shown schematically in Figure 3.7. They all employ variable speed drives and are individually calibrated to relate speed and flow rate. Ordinarily these devices are in effect manually set, but if the solid material is being fed to a reactor, some property of the mixture could be used for feed back control. The continuous belt weigher is capable ordinarily of 1% accuracy and even 0.1% when necessary. For processes such as neutralizations with lime, addition of the solid to process in slurry form is acceptable. The slurry is prepared as a batch of definite concentration and charged with a pump under flow control, often with a diaphragm pump whose stroke can be put under feedback control. For some applications it is adequate or necessary to feed weighed amounts of solids to a process on a timed basis. 

Establishment of definable end-points for the investigation of specific differences between normal and abnormal responders poses another problem. Consider the evaluation of drug treatment of hypertension as a case in point. In this instance, the definitive end-point would be measured by the difference in the incidence of strokes and cardiovascular disease between normal and abnormal drug responders, but this would probably occur years after the trait is recognized and modifying treatment undertaken. Another example of pharmacogenetic interest... 

According to the researchers, nearly half of the adverse events definitely, probably, or possibly caused by ephedra were cardiovascular side effects. The most common cardiovascular side effect was hypertension, or high blood pressure. Other reported cardiovascular events were palpitations, tachycardia (an abnormally fast heartbeat), stroke, and seizures. The researchers stated that 10 of the adverse events definitely, probably, or possibly caused by ephedra resulted in death, and 13 of the events caused permanent disability. In one-fifth of the cases, there was not enough evidence or information about the incident, and the remaining complications were not related to ephedra. 

These elfects on cerebrovascular events and on intermittent claudication suggest that simvastatin and other elfective lipid-lowering treatments may have a general antiatherosclerotic elfect not limited to the coronary bed. Definitive evidence on the elfects of statin therapy in stroke prevention and peripheral vessel disease is likely to be provided by the Heart Protection Study (MRC/BHF Heart Protection Study Collaborative Group, 1999). As noted above, this UK study has randomized over 20,000 patients aged up to 80 to simvastatin 40 mg or placebo, and the 5-year treatment period is scheduled for completion in 2001. Among these patients are 3288 patients with a history of cerebrovascular disease. Because of its size and the broad array of patient types randomized, this study should also provide reliable evidence of the elfect of simvastatin on coronary morbidity and mortality in women, elderly patients, patients with low levels of LDL and HDL cholesterol, patients with peripheral vascular disease, and diabetic patients with or without coronary disease (MRC/BHF Heart Protection Study Collaborative Group, 1999). 

The conventional definition of rangeability is the ratio between the maximum and minimum controllable flow through the valve. Minimum controllable flow (Fmin) is not the leakage flow (which occurs when the valve is closed), but the minimum flow that is still controllable and can be changed up or down as the valve stroke is changed. 

Ovbiagele B, Kidwell CS, Saver JL (2003) Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke 34 919-924 Phillips MD, McGraw P, Lowe MJ, Mathews VP, Hainline BE (2001) Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. Am J Neurora-diol 22 1583-1586... 

---